The Clorox Company
0I0J.L · London Stock Exchange · USD
106,77USD
+3,20 (+3,09 %)Stand 12. Nov., 14:04
Kennzahlen
- Eröffnung
- 107,26
- Vortag
- 103,57
- Tagesspanne
- 105,00 – 107,99
- 52 Wochen
- 79,11 – 129,00
- Volumen
- 83
- Ø Volumen
- 2205
- Börsenwert
- 12,93 Mrd. $
- KGV
- 19,2
- Gewinn je Aktie (TTM)
- 5,56
- Dividendenrendite
- 4,7 %
- Beta
- 0,9
- Nächste Zahlen
- 2. Feb. 2027
Finanzen
| USD | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Umsatz | 6,72 Mrd. | 7,1 Mrd. | 7,09 Mrd. | 7,39 Mrd. | 7,11 Mrd. |
| Herstellungskosten | 3,88 Mrd. | 3,89 Mrd. | 4,05 Mrd. | 4,48 Mrd. | 4,56 Mrd. |
| Bruttogewinn | 2,84 Mrd. | 3,21 Mrd. | 3,05 Mrd. | 2,91 Mrd. | 2,55 Mrd. |
| Forschung und Entwicklung | 116 Mio. | 121 Mio. | 126 Mio. | 138 Mio. | 132 Mio. |
| Vertrieb und Verwaltung | 1,82 Mrd. | 1,12 Mrd. | 1,99 Mrd. | 1,92 Mrd. | 1,66 Mrd. |
| Operatives Ergebnis | 913 Mio. | 1,18 Mrd. | 916 Mio. | 823 Mio. | 696 Mio. |
| EBITDA | 1,16 Mrd. | 1,17 Mrd. | 736 Mio. | 577 Mio. | 928 Mio. |
| Nettogewinn | 587 Mio. | 810 Mio. | 280 Mio. | 149 Mio. | 462 Mio. |
| Gewinn je Aktie (verwässert) | 4,81 | 6,52 | 2,25 | 1,20 | 3,73 |
Umsatz nach Segment
Produkte · FY 2025
- Health and Wellness2,7 Mrd. $38,17 %
- Household2 Mrd. $28,32 %
- Lifestyle1,3 Mrd. $18,44 %
- International1,07 Mrd. $15,07 %
Anteil · ggü. Vorjahr (FY –)
Regionen · FY 2025
- UNITED STATES6,08 Mrd. $85,59 %
- Foreign1,02 Mrd. $14,41 %
Anteil · ggü. Vorjahr (FY –)
Bewertung
Letzte 12 Monate
- KGV
- 19,2
- Kurs-Umsatz-Verhältnis
- 1,8
- Kurs-Buchwert-Verhältnis
- -333,2
- PEG
- -1,4
- Bruttomarge
- 41,9 %
- Operative Marge
- 25,1 %
- Nettomarge
- 9,4 %
- Verschuldungsgrad
- -143,4
- EV/EBITDA
- 13,9
- Eigenkapitalrendite
- −1.920,6 %
- Kapitalrendite (ROIC)
- 22,8 %
- Free-Cashflow-Rendite
- 3,5 %
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | |
|---|---|---|---|---|---|
| Bruttomarge | 42,3 % | 45,2 % | 43,0 % | 39,4 % | 35,8 % |
| Operative Marge | 13,6 % | 16,6 % | 12,9 % | 11,1 % | 9,8 % |
| Nettomarge | 8,7 % | 11,4 % | 3,9 % | 2,0 % | 6,5 % |
| KGV | 19,5 | 18,2 | 60,3 | 131,2 | 37,2 |
| Kurs-Umsatz-Verhältnis | 1,7 | 2,1 | 2,4 | 2,7 | 2,4 |
| Kurs-Buchwert-Verhältnis | 127,2 | 45,9 | 51,4 | 89,2 | 30,9 |
| Verschuldungsgrad | 61,3 | 9,0 | 8,9 | 13,3 | 5,6 |
| Liquidität 3. Grades | 0,7 | 0,8 | 1,0 | 1,0 | 1,0 |
| Dividendenrendite | 5,3 % | 4,1 % | 3,5 % | 3,0 % | 3,3 % |
| Unternehmenswert | 16,83 Mrd. | 17,45 Mrd. | 19,56 Mrd. | 22,18 Mrd. | 20,09 Mrd. |
| EV/EBITDA | 14,5 | 15,0 | 26,6 | 38,4 | 21,6 |
| Eigenkapitalrendite | 652,2 % | 252,3 % | 85,4 % | 67,7 % | 83,1 % |
| Kapitalrendite (ROIC) | 11,2 % | 24,1 % | 15,8 % | 13,4 % | 11,5 % |
| Free-Cashflow-Rendite | 3,5 % | 5,2 % | 2,9 % | 4,7 % | 3,1 % |
Wachstum
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | |
|---|---|---|---|---|---|
| Umsatz | −5,4 % | +0,2 % | −4,0 % | +4,0 % | −3,2 % |
| Bruttogewinn | −11,5 % | +5,4 % | +4,8 % | +14,3 % | −20,4 % |
| Operatives Ergebnis | −22,4 % | +28,5 % | +11,3 % | +18,2 % | −43,8 % |
| Nettogewinn | −27,5 % | +189,3 % | +87,9 % | −67,7 % | −34,9 % |
| Gewinn je Aktie | −26,2 % | +189,8 % | +87,5 % | −67,8 % | −33,2 % |
| Freier Cashflow | −46,8 % | +57,6 % | −48,1 % | +73,8 % | −43,4 % |
| Dividende je Aktie | +1,4 % | +1,7 % | +1,6 % | +1,7 % | +4,4 % |
Analysten
Einstufungen · Hold
- 0Stark kaufen
- 3Kaufen
- 22Halten
- 4Verkaufen
- 0Stark verkaufen
Kursziel
Gerade nicht verfügbar.
Schätzungen
| FY 2027 | FY 2028 | FY 2029 | |
|---|---|---|---|
| Umsatz (Ø) | 7,64 Mrd. | 7,81 Mrd. | 8 Mrd. |
| Umsatz (Tief – Hoch) | 7,61 Mrd. – 7,67 Mrd. | 7,68 Mrd. – 7,91 Mrd. | 7,91 Mrd. – 8,06 Mrd. |
| Gewinn je Aktie (Ø) | 5,72 | 6,15 | 6,59 |
| Gewinn je Aktie (Tief – Hoch) | 5,65 – 5,79 | 6,07 – 6,22 | 6,50 – 6,66 |
| Analysten | 1 | 1 | 1 |
Letzte Änderungen
- Morgan Stanley4. Nov. 2026Equal Weight
- Wells Fargo3. Nov. 2026Equal Weight
- JP Morgan3. Nov. 2026Underweight
- UBS3. Nov. 2026Neutral
- Evercore ISI Group2. Nov. 2026Underperform → In Line
- JP Morgan19. Okt. 2026Underweight
- Barclays16. Okt. 2026Underweight
- Morgan Stanley15. Okt. 2026Equal Weight
Quartalszahlen
Nächste Zahlen: 2. Feb. 2027| Nov. 2026 | Aug. 2026 | Apr. 2026 | Feb. 2026 | Nov. 2025 | Juli 2025 | Mai 2025 | Feb. 2025 | |
|---|---|---|---|---|---|---|---|---|
| Gewinn je Aktie · Erwartet | 1,07 | 1,64 | 1,55 | 1,43 | 0,78 | 2,20 | 1,55 | 1,40 |
| Gewinn je Aktie · Tatsächlich | 1,55 | 1,66 | 1,64 | 1,39 | 0,85 | 2,87 | 1,45 | 1,55 |
| Abweichung | +44,86 % | +1,22 % | +5,81 % | −2,80 % | +9,25 % | +30,45 % | −6,45 % | +10,71 % |
| Umsatz · Tatsächlich | 1,91 Mrd. | 1,95 Mrd. | 1,67 Mrd. | 1,67 Mrd. | 1,43 Mrd. | 1,99 Mrd. | 1,67 Mrd. | 1,69 Mrd. |
Dividenden und Splits
| Ex-Tag | Zahltag | Betrag |
|---|---|---|
| 28. Okt. 2026 | 13. Nov. 2026 | 1,25 |
| 12. Aug. 2026 | 28. Aug. 2026 | 1,25 |
| 22. Apr. 2026 | 8. Mai 2026 | 1,24 |
| 28. Jan. 2026 | 13. Feb. 2026 | 1,24 |
| 22. Okt. 2025 | 6. Nov. 2025 | 1,24 |
| 13. Aug. 2025 | 29. Aug. 2025 | 1,24 |
| 23. Apr. 2025 | 9. Mai 2025 | 1,22 |
| 29. Jan. 2025 | 14. Feb. 2025 | 1,22 |
| 23. Okt. 2024 | 7. Nov. 2024 | 1,22 |
| 14. Aug. 2024 | 30. Aug. 2024 | 1,22 |
| 23. Apr. 2024 | 10. Mai 2024 | 1,20 |
| 23. Jan. 2024 | 9. Feb. 2024 | 1,20 |
Aktiensplits
–
Eigentümer
Institutionen
Gerade nicht verfügbar.
Insider-Geschäfte
–
Vergleichbare Unternehmen
CHDChurch & Dwight Co., Inc.112,02+0,23 %
CLColgate-Palmolive Company98,00−0,09 %
EPCEdgewell Personal Care Company29,15−1,55 %
HELEHelen of Troy Limited37,99−0,56 %
KMBKimberly-Clark Corporation108,86−1,72 %
KVUEKenvue Inc.19,31−1,28 %
PGThe Procter & Gamble Company167,67−0,59 %
REYNReynolds Consumer Products Inc.24,81−0,72 %
Über das Unternehmen
The Clorox Company operates as a global enterprise, producing and distributing a wide array of consumer and professional goods. Its operations are organized into four key divisions: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness division encompasses a variety of cleaning solutions, such as laundry additives and general home care products, sold under prominent names like Clorox, Pine-Sol, and Liquid-Plumr. It also supplies professional cleaning and disinfecting agents through CloroxPro and Clorox Healthcare, and specialized food service items via the Hidden Valley brand. Furthermore, in the United States, this segment offers vitamins, minerals, and supplements (VMS) from brands including RenewLife, Natural Vitality, NeoCell, and Rainbow Light. The Household segment primarily caters to the U.S. market, focusing on pet care products like cat litter under the Fresh Step and Scoop Away brands, alongside food storage solutions such as bags and wraps from the Glad brand, and grilling essentials provided by Kingsford. Focused on the U.S., the Lifestyle division presents a range of culinary offerings such as dressings, dips, and sauces, predominantly under the Hidden Valley banner. It also includes natural personal care items from Burt's Bees and water purification systems through the Brita brand. Globally, the International segment extends a diverse portfolio mirroring many of the company's domestic offerings, including laundry aids, home care products, water filtration devices, digestive health solutions, grilling charcoal, cat litter, various food products, bags and wraps, natural personal care lines, and professional cleaning and disinfecting supplies. These are marketed across various regions under well-known international and local brands such as Clorox, Glad, Brita, RenewLife, Ever Clean, and Burt's Bees, alongside regional staples like Ayudin, Clorinda, and Poett. Clorox products reach consumers and businesses through an extensive distribution network. This includes major mass retailers, grocery chains, warehouse clubs, discount stores, home improvement centers, pharmacies, pet stores, military commissaries, dedicated e-commerce platforms (both owned and third-party), and through a vast network of distributors supported by a direct sales force. Established in 1913, the company maintains its headquarters in Oakland, California.
Führung
- Linda RendleChief Executive Officer & Chairman
- Nina BartonExecutive VP and Chief Growth & Strategy Officer
- Luc BelletExecutive Vice President & Chief Financial Officer
- Kirsten MarrinerExecutive Vice President & Chief Administrative Officer
- Chris T. HyderExecutive VP & COO
- Angela C. HiltExecutive Vice President, Chief Legal & External Affairs Officer and Corporate Secretary
- CEO
- Linda J. Rendle
- Mitarbeitende
- 9.200
- Hauptsitz
- Oakland, CA, US
- Sektor
- Consumer Defensive
- Branche
- Household & Personal Products
- Börsengang
- 29. Jan. 2018
- Website
- thecloroxcompany.com
Nachrichten
Gerade keine Nachrichten zu diesem Unternehmen.
Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.